Sage Therapeutics Inc.

(SAGE) Trade

By |

Profile

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. Sage's lead development program is SAGE-547, it is in Phase 3 clinical trials for super-refractory status epilepticus; and the SAGE-217 program which is in Phase 2 clinical trials for post-partum depression, essential tremor, Parkinson's disease and major depressive disorder. The company is also developing several other compounds for treatment that is in the early stage of development.

Contact Information

Website: www.sagerx.com
Email: paul.cox@sagerx.com
Main Phone: +1 617 299-8380
Address: 215 First Street
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSD
CEO: Jeffrey M. Jonas
Employees: 257
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 110.65 $ 2.81 (2.61%)
Last Price 110.65 Change $ 2.81 Change % 2.61 Tick N/A
Bid 106.20 Bid Size 200.00 Ask 113.00 Ask Size 200.00
Open 108.84 High 112.12 Low 107.33 Prev Close 107.84
Last Trade Volume 378,790 52 Wk Hi 195.97 52 Wk Low 100.16
Market Cap 5.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 46,887,174.00 EPS (TTM) -6.39 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 23 58
Number of Buys 1 5
Number of Sells 22 53
Net Activity -99935 -2147628
Last 10 Buys Shares
Jeffrey M. Jonas 1,000
Kimi Iguchi 1,000
Stephen J. Kanes 1,000
James M. Frates 1,000
Albert J. Robichaud 1,000
Steven M. Paul 1,000
Kimi Iguchi 1,000
Last 10 Sell Shares
James M. Frates 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
Kimi Iguchi 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 225 225 225 261
Low Target Price Estimate 112 112 112 193
Mean Target Price Estimate 195.57 195.57 195.57 214.6
Standard Deviation 35.74 35.74 35.74 16.94
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/14/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 11 10 10 10
Moderate Buy 1 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.04 1.13 1.13 1.13